{"source": ["It is the end stage of many forms of liver disease.", "If you'd like to know more about living donor transplants, ask your hepatologist or liver specialist, your surgeon or your transplant coordinator.", "Although detection of total antibodies by enzyme immunoassay ELISA is the diagnostic test of choice 2-4, false negatives can occur in immunocompromised patients suffering from renal failure or cryoglobulinemia associated with HCV 3.", "Phagocytosis and cellular death.", "b Liver: cases of hepatitis with necrosis, steatosis and Councilman bodies probably apoptotic cells have been reported in association with DENV.", "In the United States, Desai et al 26 examined 55 patients with SBP and found that 40% of cultures tested positive for SBP with 20% testing positive for gram-negative bacteria and 5.5% testing positive for more than one microorganism.", "The cause of many diseases is insufficient liver function.", "Although thrombosis of the hepatic artery occurs in less than 5% of adult patients following LT, it is a catastrophic event which is related to 53% of graft losses and 30% of mortality cases 29.", "The latter antibodies maximize a subsequent infection with an heterologous serotype, by enhancing the entry of the virus with Fc-\u03b3 receptors in monocytes and macrophages, achieving not only a larger number of infected cells, but also an increase in the viral replication in its target cell and, as a consequence, increasing vascular permeability.", "The liver was affected.", "Anti-liver cytosol antibody type 1 anti-LC1 is a marker for type 2 autoimmune hepatitis which generally presents with LKM1 but which may also be the only autoantibody found 40.", "Similarly, a study that included 248 BCS patients from 51 European centers who underwent liver transplantation showed a one year survival rate of 76%, a five year survival rate of 71%, and a ten year survival rate of 68% 32.", "Research conducted by scientists at the Spanish National Cancer Research Centre (CNIO) reveals how hepatocytes \"recruit\" and \"instruct\" liver progenitor cells to contribute to the hepatic lesions.", "Liver retransplantation is the only definitive treatment option in chronic graft dysfunction no matter what the cause.", "The risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease and cirrhosis (NAFLD-cirrhosis) is unknown and needs to be systematically quantified.", "A Chinese doctor told German surgeon Dr. Torsten Trey in 2006 that a Tianjin hospital conducted 2,000 liver transplants per year.[52]", "Liver transplantation has become the choice treatment for patients with terminal hepatic illness 6.", "The majority of authors on this topic consider the presence of fat, ballooning and hepatocyte injury to be the minimum histopathological changes required for establishing a diagnosis of NASH which evolves into advanced fibrosis Figure 9 and cirrhosis in between 25% and 30% of these cases.", "In this study, three cirrhotic individuals presented SBP as the result of infections with two germs, but secondary peritonitis was not confirmed in either case 46.", "During liver transplantation, hypocalcaemia is multifactorial: transfusions, diminished metabolic capacity of the liver, and reduced liver blood flow.", "This will directly result in damage/necrosis of hepatocytes and other metabolically active cells, leading to reduction of body weight, behavioral abnormalities, yellowing of the body surface, and immune suppression , , , , , .", "In conclusion, liver retransplantation is a complex procedure associated with a greater number of complications and with outcomes that are not as good as those of first transplants at our center. Medium-term results are similar to those described in other centers elsewhere in the world.", "Introduction: Hepatocellular carcinoma HCC is one of the complications associated with liver cirrhosis LC.", "Chronic hepatitis is the most important presentation of HCV infection. It develops in up to 85% of cases and of this percentage about 20% develop liver cirrhosis LC which in turn entails an annual risk of 1% to 4% of developing hepatocellular carcinoma Figure 1 4, 5, 8-9.", "We observe hepatocytes that are greatly diminished in size with rhomboid or rounded forms with intensely eosinophilic cytoplasm and dark or pyknotic nuclei.", "The most common are: - Panlobular compromise with giant cell transformation in which hepatocytes are very large with many nuclei between 3 and 20 nuclei. This represents a hepatic response to damage and is seen especially in this age group Figures 5 A and B. It is unusual in adults.", "Various studies have demonstrated that when diagnostic criteria are used appropriately 2/3 of all cases characterized as cryptogenic cirrhosis turn out to really be cases of NAFLD/NASH 130.", "For controls, 5 serums with anti-HCV antibodies and 5 serums which were negative for HCV were obtained from the Public Health Department Laboratory in Santander.", "\u201cBased on the preclinical and clinical studies we\u2019ve conducted, CRV431\u2019s anti-fibrotic and anti-inflammatory properties demonstrate its significant potential as a novel therapy for NASH, and more broadly, for liver disease.\u201d", "There are many other causes of fatty liver disease that are considered to be secondary. The size of the vacuole can help us in the search for an etiologic factor. For instance, a large vacuole is seen in rapid weight loss and malnutrition and is associated with Hepatitis C; genetic metabolic disorders such as Wilson's disease, tyrosinemia and abetalipoproteinemia; other conditions such as congenital lipodystrophy and lipodystrophy acquired through HIV infection; large intestinal resections; gastroplasties and jejunoileal bypasses.", "When the molecular phylogenetic analysis of the detected isolates was done, it was found that both strains belonged to genotype 1a, thus showing that the same agent was the trigger for the manifestations of hepatic failure.", "A literature search was conducted on the main medical databases including MEDLINE, SciELO and EMBASE for papers published between July 1990 and November 2010 looking at technologies associated with liver support systems, their technical specifications, their use, and evidence regarding their effectiveness in patients with some forms of liver failure requiring support.", "The study proportion was one woman for every 1.31 men. Base pathologies of auto-immune illnesses and cryptogenic cirrhosis were more common among women.", "The clearest existing relation between hepothiliasis and CC is in Taiwan where 70% of the patients who have hepatic resections due to CC, also have hepatolithiasis 10.", "This protein is produced primarily by the liver. Macrophages and adipocytes bind hepcidin to the ferroportin of the cell membrane. This generates internalization with a resulting decrease in expression of ferroportin within the membrane.", "The most common is chronic hepatitis no different than in patients who have not undergone transplantation except that viremia is greater and progression to cirrhosis occurs in only 5 to10 years 49 Other patients < 10% present fibrosing cholestatic hepatitis, a severe condition related to high viral loads in patients with strong immunosuppression.", "SBP normally occurs in the final stage of liver diseases and has a high rate of recurrence, about 70% in one year 5-7.", "Fatty liver is defined as an ultrasound finding of hepatic steatosis with or without inflammation and/or a finding of fibrosis in the absence of the secondary causes listed below 5-6:", "They recommend testing for HBsAg, anti-HBc, anti-HBsAg and aminotransferases levels in patients who may be treated with chemotherapy or immunosuppressants so that complications from reactivation of the virus can be avoided.", "Patients with chronic hepatic disease, who have serious histological damage and a history of HBV reactivation, as was the case of our patient, must be treated with powerful antiviral medications with high genetic barriers that prevent the appearance of resistance. These characteristics are present in nucleoside analogs such as entecavir or tenofovir.", "The transplanted livers come from deceased donors, although a small number comes from living donors who donate a portion of their livers.", "This application contains information specifically related to liver disease.", "The seven-day successful perfusion of poor-quality livers now allows for a wide range of strategies, e.g. repair of a preexisting injury, cleaning of fat deposits in the liver or even regeneration of partial livers.", "Progressive deterioration of hepatic function led to severe liver insufficiency and death four days after admission.", "The main cause of death was primary liver graft dysfunction.", "(2017) Alcoholic liver disease: pathogenesis and current management.", "Based on the above considerations, this study's goals were to identify the microorganisms found in ascitic fluid cultures and to describe the clinical characteristics related to the presence of infections in the ascitic fluid of patients with cirrhosis.", "In Egypt, Abd Elaal et al 36 evaluated 36 patients with SBP. Among these patients 12 patients had ascitic fluid cultures that were positive for SBP.", "HPS can also occur in acute liver diseases such as viral hepatitis and hepatic failure 4. To date, there have been few cases and series that report the presence of HPS together with cirrhotic portal hypertension. The characteristics of these patients have not yet been fully studied 5.", "They were initially described in 1911 by Dr. Frank D Mallory in relation to alcoholic hepatitis but have been observed in a number of other liver diseases including nonalcoholic steatohepatitis NASH, Wilson's disease, chronic cholestatic diseases, toxic reactions to medications such as amiodarone, and hepatocellular carcinoma.", "A viral genome was detected in samples of the native liver tissue and from the first graft.", "A study of 76 men who drank more than 216 grams/day for more than 24 years found that only 22% presented abnormal liver histology. Although 30% had vertebral compression fractures, only 4% were symptomatic.", "These patients should also undergo drug therapy 15 and bariatric surgery 16 to control the process of fibrosis and progression toward chronic liver disease.", "Hepatic transplant was performed when patients had cirrhosis or bilateral hepatic compromise which was not susceptible to endoscopic treatment, radiological intervention or smaller hepatic resections.", "Treatment is based on modification of lifestyle and risk factors including encouragement of exercise, weight loss, a healthy low-calorie diet, and continuous monitoring for early detection of fibrosis and/or cirrhosis. In addition, effective therapies with minimal side effects have been developed to control the progression of the disease. These include administration of antioxidants such as vitamins E and C which have been shown to reverse high levels of transaminases, cholesterol and hyaluronic acid although they do not reverse elevated levels of cytokines and inflammation does not improve 4, 6, 18, 41.", "Recently sibutramine was taken off the market because of its cardiovascular effects, while Orlistat has been associated with isolated cases of fulminant hepatic failure.", "The curative action elimination of dormant liver stage parasites DLSP: hypnozoites depends on:", "At this time, liver transplants are reserved for those with small tumors (either 1 tumor smaller than 5 cm or 2 to 3 tumors no larger than 3 cm) that have not invaded nearby blood vessels.", "Left lobe hepatolithiasis was most frequent 36%, followed by bilateral hepatolithiasis 34%.", "Terminal liver disease secondary to HCV infection is one of the most frequent indications for liver transplantation in the United States and Western Europe 3."], "hyp": ["\u5b83\u662f\u591a\u79cd\u5f62\u5f0f\u809d\u75c5\u7684\u7ed3\u675f\u9636\u6bb5\u3002", "\u5982\u679c\u4f60\u60f3\u77e5\u9053\u66f4\u591a\u5173\u4e8e\u6d3b\u4f53\u6350\u8d60\u8005\u79fb\u690d\u7684\u4fe1\u606f \u95ee\u95ee\u4f60\u7684\u809d\u810f\u4e13\u5bb6 \u809d\u810f\u4e13\u5bb6 \u5916\u79d1\u533b\u751f \u79fb\u690d\u534f\u8c03\u5458", "\u867d\u7136\u901a\u8fc7\u9176\u514d\u75ab\u7d20\u5b66ELISA\u68c0\u6d4b\u5230\u603b\u6297\u4f53\u662f\u7b2c2-4\u9879\u9009\u62e9\u7684\u8bca\u65ad\u6d4b\u8bd5,\u4f46\u5728\u4e0eHCV 3\u6709\u5173\u7684\u80be\u8870\u7aed\u6216\u4f4e\u6e29\u8840\u7403\u8840\u75c7\u7684\u514d\u75ab\u8150\u70c2\u75c5\u4eba\u4e2d,\u53ef\u80fd\u4f1a\u51fa\u73b0\u5047\u9634\u6027\u53cd\u5e94\u3002", "\u7ec6\u80de\u7ec6\u80de\u5206\u88c2\u548c\u7ec6\u80de\u6b7b\u4ea1", "b \u809d\u810f:\u5df2\u62a5\u544a\u4e0eDENV\u6709\u5173\u7684\u809d\u708e\u3001\u574f\u6b7b\u3001\u80c3\u75c5\u548c\u7406\u4e8b\u4f1a\u6210\u5458\u5c38\u4f53\u53ef\u80fd\u4e3a\u7f3a\u8840\u7ec6\u80de\u3002", "\u5728\u7f8e\u56fd,Desai\u7b49\u4eba26\u4eba\u68c0\u67e5\u4e8655\u540d\u60a3\u6709\u767d\u5589\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u3002", "\u8bb8\u591a\u75be\u75c5\u7684\u539f\u56e0\u662f\u809d\u529f\u80fd\u4e0d\u8db3\u3002", "\u867d\u7136\u809d\u52a8\u8109\u8840\u6813\u75c7\u5728LT\u540e\u53d1\u751f\u5728\u4e0d\u8db35%\u7684\u6210\u5e74\u75c5\u4eba\u4e2d,\u4f46\u8fd9\u662f\u4e00\u4e2a\u707e\u96be\u6027\u4e8b\u4ef6,\u4e0e53%\u7684\u79fb\u690d\u635f\u5931\u548c30%\u768429\u4f8b\u6b7b\u4ea1\u75c5\u4f8b\u6709\u5173\u3002", "\u540e\u4e00\u79cd\u6297\u4f53\u901a\u8fc7\u5c06\u75c5\u6bd2\u4e0eFc-\u03b3\u53d7\u4f53\u66f4\u591a\u5730\u8f93\u5165\u5355\u7ec6\u80de\u548c\u5927\u578b\u7ec6\u80de,\u4e0d\u4ec5\u5b9e\u73b0\u66f4\u591a\u7684\u53d7\u611f\u67d3\u7ec6\u80de,\u800c\u4e14\u5176\u76ee\u6807\u7ec6\u80de\u7684\u75c5\u6bd2\u590d\u5236\u91cf\u589e\u52a0,\u4ece\u800c\u589e\u52a0\u8840\u7ba1\u6e17\u900f\u6027,\u4ece\u800c\u5c3d\u53ef\u80fd\u4f7f\u540e\u4e00\u79cd\u8840\u6e05\u578b\u7684\u611f\u67d3\u6700\u5927\u5316\u3002", "\u809d\u810f\u53d7\u5230\u5f71\u54cd\u3002", "\u53cdLC1\u578b1\u578b\u6297\u4f53\u7684\u6297\u6392\u5916\u7ec6\u80de\u7d22\u662f\u4e00\u79cd2\u578b\u81ea\u52a8\u514d\u75ab\u6027\u809d\u708e\u7684\u6807\u8bb0,\u4e00\u822c\u4e3aLKM1\u578b,\u4f46\u4e5f\u53ef\u80fd\u662f\u552f\u4e00\u768440\u578b\u81ea\u53d1\u6027\u4f53\u3002", "\u540c\u6837,\u4e00\u9879\u5305\u62ec\u6765\u81ea51\u4e2a\u6b27\u6d32\u4e2d\u5fc3\u7684248\u540d\u63a5\u53d7\u809d\u810f\u79fb\u690d\u7684BCS\u75c5\u4eba\u7684\u7814\u7a76\u663e\u793a,1\u5e74\u5b58\u6d3b\u7387\u4e3a76%,5\u5e74\u5b58\u6d3b\u7387\u4e3a71%,10\u5e74\u5b58\u6d3b\u7387\u4e3a68%,32\u5e74\u5b58\u6d3b\u7387\u4e3a68%\u3002", "\u897f\u73ed\u7259\u56fd\u5bb6\u764c\u75c7\u7814\u7a76\u4e2d\u5fc3(CNIO)\u79d1\u5b66\u5bb6\u8fdb\u884c\u7684\u7814\u7a76\u63ed\u793a\u4e86\u809d\u7ec6\u80de\u201c\u751f\u6b96\u5668\u201d\u548c\u201c\u4eba\u5de5\u201d\u809d\u751f\u6b96\u7ec6\u80de\u662f\u5982\u4f55\u4fc3\u6210\u809d\u635f\u4f24\u7684\u3002", "\u809d\u810f\u518d\u79fb\u690d\u662f\u6162\u6027\u79fb\u690d\u673a\u80fd\u969c\u788d\u7684\u552f\u4e00\u6700\u7ec8\u6cbb\u7597\u9009\u62e9,\u65e0\u8bba\u539f\u56e0\u4e3a\u4f55\u3002", "\u975e\u9152\u7cbe\u8102\u80aa\u809d\u75c5\u548c\u809d\u786c\u5316(NAFLD-\u809d\u786c\u5316)\u60a3\u8005\u7684\u4e00\u7ea7\u4eb2\u5c5e\u6709\u4e25\u91cd\u7ea4\u7ef4\u5316\u7684\u98ce\u9669\u5c1a\u4e0d\u5f97\u800c\u77e5,\u9700\u8981\u7cfb\u7edf\u5730\u91cf\u5316\u3002", "\u4e2d\u56fd\u533b\u751f2006\u5e74\u544a\u8bc9\u5fb7\u56fd\u5916\u79d1\u533b\u751fTorsten Trey\u533b\u751f,\u5929\u6d25\u533b\u9662\u6bcf\u5e74\u8fdb\u884c2 000\u6b21\u809d\u79fb\u690d\u3002 [52]", "\u809d\u79fb\u690d\u5df2\u6210\u4e3a\u5bf96\u540d\u7edd\u75c7\u809d\u75c5\u60a3\u8005\u7684\u9996\u9009\u6cbb\u7597\u3002", "\u8fd9\u4e00\u4e13\u9898\u7684\u5927\u591a\u6570\u4f5c\u8005\u8ba4\u4e3a,\u8102\u80aa\u3001\u6c14\u7403\u548c\u809d\u7ec6\u80de\u635f\u4f24\u7684\u5b58\u5728\u662f\u786e\u5b9aNASH\u8bca\u65ad\u6240\u9700\u7684\u6700\u4f4e\u9650\u5ea6\u7684\u75c5\u7406\u5b66\u53d8\u5316,\u8fd9\u79cd\u8bca\u65ad\u6f14\u53d8\u4e3a\u5148\u8fdb\u7684\u7ea4\u7ef4\u5316\u56fe9\u548c25%\u81f330%\u7684\u75c5\u4f8b\u7684\u809d\u786c\u5316\u3002", "\u5728\u8fd9\u6b21\u7814\u7a76\u4e2d,\u7531\u4e8e\u611f\u67d3\u4e86\u4e24\u79cd\u7ec6\u83cc,\u67093\u540d\u809d\u786c\u5316\u8005\u63d0\u4ea4\u4e86\u56fd\u5bb6\u80ba\u7ed3\u6838\u5c40,\u4f46\u5728\u7b2c46\u4e2a\u75c5\u4f8b\u4e2d,\u4e8c\u7ea7\u8179\u819c\u708e\u5747\u672a\u5f97\u5230\u8bc1\u5b9e\u3002", "\u5728\u809d\u810f\u79fb\u690d\u671f\u95f4,\u4f4e\u8840\u538b\u662f\u591a\u65b9\u9762\u7684:\u8f93\u8840\u3001\u809d\u810f\u65b0\u9648\u4ee3\u8c22\u80fd\u529b\u964d\u4f4e\u3001\u809d\u8840\u6d41\u51cf\u5c11\u3002", "\u8fd9\u5c06\u76f4\u63a5\u5bfc\u81f4\u809d\u7ec6\u80de\u548c\u5176\u4ed6\u4ee3\u8c22\u6d3b\u6027\u7ec6\u80de\u7684\u635f\u4f24/\u574f\u6b7b,\u5bfc\u81f4\u4f53\u91cd\u51cf\u5c11\u3001\u884c\u4e3a\u5f02\u5e38\u3001\u8eab\u4f53\u8868\u9762\u9ec4\u8272\u548c\u514d\u75ab\u6291\u5236\u3001\u3001 \u3001 \u3001 \u3001 \u3001 \u3001 \u3001 \u3001 \u3001 \u3002", "\u6700\u540e,\u809d\u810f\u518d\u79fb\u690d\u662f\u4e00\u4e2a\u590d\u6742\u7684\u8fc7\u7a0b,\u4e0e\u66f4\u591a\u7684\u5e76\u53d1\u75c7\u548c\u7ed3\u679c\u76f8\u5173\u8054,\u7ed3\u679c\u4e0d\u5982\u6211\u4eec\u4e2d\u5fc3\u9996\u6b21\u79fb\u690d\u7684\u7ed3\u679c\u3002 \u4e2d\u671f\u7ed3\u679c\u4e0e\u4e16\u754c\u5176\u4ed6\u5730\u65b9\u4e2d\u5fc3\u63cf\u8ff0\u7684\u7ed3\u679c\u76f8\u4f3c\u3002", "\u5bfc \u8a00:\u809d\u7ec6\u80de\u764c\u662f\u809d\u786c\u5316LC\u5f15\u8d77\u7684\u5e76\u53d1\u75c7\u4e4b\u4e00\u3002", "\u6162\u6027\u809d\u708e\u662f\u4e59\u578b\u809d\u708e\u611f\u67d3\u6700\u91cd\u8981\u7684\u8868\u73b0\u65b9\u5f0f,\u572885%\u7684\u75c5\u4f8b\u4e2d\u51fa\u73b0\u6162\u6027\u809d\u708e,\u5176\u4e2d\u7ea620%\u7684\u75c5\u4f8b\u51fa\u73b0\u809d\u786c\u5316LC,\u8fd9\u53cd\u8fc7\u6765\u53c8\u5e26\u6765\u6bcf\u5e741%\u81f34%\u7684\u809d\u7ec6\u80de\u764c\u98ce\u9669,\u56fe14\u30015\u30018-9\u3002", "\u6211\u4eec\u89c2\u5bdf\u5230\u7684\u809d\u7ec6\u80de\u4f53\u79ef\u5927\u4e3a\u51cf\u5c11,\u6709\u4f26\u535a\u57fa\u6216\u56db\u820d\u4e94\u5165\u7684\u8840\u7ec6\u80de,\u6709\u5f3a\u70c8\u7684\u9aa8\u7ec6\u80de\u7ec6\u80de\u7ec6\u80de,\u6709\u6697\u7684\u6216\u6e7f\u7684\u6838\u7ec6\u80de\u3002", "\u6700\u5e38\u89c1\u7684\u662f: - \u5de8\u578b\u7ec6\u80de\u53d8\u5f02\u7684\u677f\u5757\u59a5\u534f,\u809d\u7ec6\u80de\u975e\u5e38\u5927,\u8bb8\u591a\u6838\u57283\u523020\u4e2a\u6838\u4e4b\u95f4,\u8fd9\u662f\u5bf9\u635f\u5bb3\u7684\u4e00\u79cd\u809d\u810f\u53cd\u5e94,\u5728\u56fe5 A\u548c\u56feB\u8fd9\u4e00\u5e74\u9f84\u7ec4\u4e2d\u5c24\u4e3a\u660e\u663e\u3002 \u5728\u6210\u5e74\u4eba\u4e2d,\u8fd9\u662f\u4e0d\u5bfb\u5e38\u7684\u3002", "\u5404\u79cd\u7814\u7a76\u663e\u793a,\u5728\u6240\u6709\u88ab\u5b9a\u6027\u4e3a\u4f4e\u6e29\u809d\u786c\u5316\u7684\u6240\u6709\u75c5\u4f8b\u4e2d,\u5982\u679c\u9002\u5f53\u4f7f\u7528\u8bca\u65ad\u6807\u51c6,\u67092/3\u786e\u786e\u5b9e\u5b9e\u662f130\u4e2a\u5168\u56fd\u827e\u6ecb\u75c5\u75ab\u82d7\u548c\u514d\u75ab\u7f3a\u9677\u7efc\u5408\u5f81/\u7eb3\u4ec0\u5361\u75c5\u4f8b\u3002", "\u4e3a\u4e86\u63a7\u5236,\u4ece\u6851\u5766\u5fb7\u516c\u5171\u536b\u751f\u90e8\u5b9e\u9a8c\u5ba4\u83b7\u5f97\u4e865\u79cd\u6297HCV\u6297\u4f53\u8840\u6e05\u548c5\u79cd\u5bf9HCV\u5448\u9634\u6027\u7684\u8840\u6e05\u3002", "CRV431\u7684\u6297\u80ba\u708e\u548c\u6297\u708e\u6027\u80fd\u8bc1\u660e\u4e86\u5b83\u4f5c\u4e3aNASH\u7684\u65b0\u7597\u6cd5\u4ee5\u53ca\u66f4\u5e7f\u6cdb\u5730\u8bf4\u4f5c\u4e3a\u809d\u75c5\u7684\u65b0\u7597\u6cd5\u7684\u5de8\u5927\u6f5c\u529b\u3002", "\u8102\u80aa\u809d\u75c5\u7684\u8bb8\u591a\u5176\u4ed6\u539f\u56e0\u88ab\u8ba4\u4e3a\u662f\u6b21\u8981\u7684,\u771f\u7a7a\u4f53\u79ef\u53ef\u4ee5\u5e2e\u52a9\u6211\u4eec\u5bfb\u627e\u4e00\u79cd\u75c5\u56e0,\u4f8b\u5982,\u5927\u91cf\u771f\u7a7a\u4f53\u5728\u5feb\u901f\u4f53\u91cd\u51cf\u9000\u548c\u8425\u517b\u4e0d\u826f\u4e2d\u51fa\u73b0,\u5e76\u4e14\u4e0e\u4e19\u578b\u809d\u708e\u6709\u5173;\u9057\u4f20\u6027\u4ee3\u8c22\u75be\u75c5,\u5982\u5a01\u5c14\u900a\u75c5\u3001\u5f3a\u8840\u7cd6\u548c\u4e59\u9178\u86cb\u767d\u8840\u75c5;\u5176\u4ed6\u6761\u4ef6,\u5982\u5148\u5929\u6027\u8102\u8d28\u840e\u7f29\u548c\u901a\u8fc7\u827e\u6ecb\u75c5\u6bd2\u611f\u67d3\u83b7\u5f97\u7684\u8102\u8d28\u840e\u7f29;\u5927\u80a0\u5207\u9664;\u80c3\u90e8\u548c\u9634\u9053\u7ed5\u884c\u3002", "\u5728\u5bf9\u6240\u68c0\u6d4b\u5230\u7684\u5206\u79bb\u7269\u8fdb\u884c\u5206\u5b50\u751f\u7406\u9057\u4f20\u5b66\u5206\u6790\u65f6,\u53d1\u73b0\u8fd9\u4e24\u79cd\u83cc\u682a\u90fd\u5c5e\u4e8e\u57fa\u56e0\u578b1a,\u4ece\u800c\u8868\u660e\u540c\u4e00\u7269\u5242\u662f\u809d\u8870\u7aed\u75c7\u72b6\u7684\u8bf1\u56e0\u3002", "\u5bf9\u5305\u62ecMEDLINE\u3001SciELO\u548cEMBASE\u5728\u5185\u7684\u4e3b\u8981\u533b\u7597\u6570\u636e\u5e93\u8fdb\u884c\u4e86\u6587\u732e\u641c\u7d22,\u4ee5\u67e5\u96051990\u5e747\u6708\u81f32010\u5e7411\u6708\u51fa\u7248\u7684\u8bba\u6587,\u7814\u7a76\u4e0e\u809d\u810f\u652f\u6301\u7cfb\u7edf\u6709\u5173\u7684\u6280\u672f\u3001\u5176\u6280\u672f\u89c4\u683c\u3001\u5176\u4f7f\u7528,\u4ee5\u53ca\u5173\u4e8e\u8fd9\u4e9b\u6280\u672f\u5bf9\u9700\u8981\u652f\u6301\u7684\u67d0\u79cd\u809d\u810f\u8870\u7aed\u60a3\u8005\u7684\u6709\u6548\u6027\u7684\u8bc1\u636e\u3002", "\u7814\u7a76\u6bd4\u4f8b\u4e3a\u6bcf1.31\u540d\u7537\u5b50\u4e2d\u6709\u4e00\u540d\u5987\u5973,\u81ea\u53d1\u514d\u75ab\u6027\u75be\u75c5\u548c\u4f4e\u6e29\u6027\u809d\u786c\u5316\u75c7\u7684\u57fa\u7840\u75c5\u5728\u5987\u5973\u4e2d\u66f4\u4e3a\u5e38\u89c1\u3002", "\u8840\u5438\u866b\u75c5\u4e0eCC\u4e4b\u95f4\u6700\u660e\u663e\u7684\u73b0\u6709\u5173\u7cfb\u5728\u53f0\u6e7e,70%\u56e0CC\u800c\u51fa\u73b0\u809d\u810f\u5207\u9664\u7684\u75c5\u4eba\u4e5f\u670910\u79cd\u809d\u708e\u3002", "\u8fd9\u79cd\u86cb\u767d\u8d28\u4e3b\u8981\u7531\u809d\u810f\u4ea7\u751f,\u5927\u578b\u57fa\u56e0\u548c\u4e8c\u5206\u7ec6\u80de\u7ec6\u80de\u7ec6\u80de\u5c06\u809d\u7d20\u4e0e\u7ec6\u80de\u819c\u7684\u94c1\u8d28\u53f6\u7d20\u7ed3\u5408,\u4ece\u800c\u4ea7\u751f\u5185\u5316,\u5bfc\u81f4\u819c\u5185\u94c1\u8d28\u7d20\u7684\u8868\u8fbe\u65b9\u5f0f\u4e0b\u964d\u3002", "\u6700\u5e38\u89c1\u7684\u662f\u6162\u6027\u809d\u708e,\u4e0e\u672a\u8fdb\u884c\u79fb\u690d\u7684\u75c5\u4eba\u6ca1\u6709\u533a\u522b,\u53ea\u662f\u75c5\u6bd2\u6027\u8d2b\u8840\u75c7\u66f4\u5927,\u4ec55\u81f310\u5e74\u5c31\u51fa\u73b0\u809d\u786c\u5316\u3002 49 \u5176\u4ed6\u75c5\u4eba\u572810%\u4ee5\u4e0b\u51fa\u73b0\u7ec6\u80de\u7ea4\u7ef4\u5316\u80c6\u56fa\u9187\u809d\u708e,\u8fd9\u662f\u4e0e\u5f3a\u514d\u75ab\u6291\u5236\u75c5\u4eba\u7684\u9ad8\u75c5\u6bd2\u8d1f\u8377\u6709\u5173\u7684\u4e25\u91cd\u75be\u75c5\u3002", "SBP\u901a\u5e38\u53d1\u751f\u5728\u809d\u75c5\u7684\u6700\u540e\u9636\u6bb5,\u5176\u590d\u53d1\u7387\u5f88\u9ad8,\u57281\u5e745-7\u7684\u5e74\u4efd\u4e2d\u7ea6\u4e3a70%\u3002", "\u8102\u80aa\u809d\u810f\u7684\u5b9a\u4e49\u662f,\u5728\u6ca1\u6709\u4ee5\u4e0b5-6\u6240\u5217\u6b21\u8981\u539f\u56e0\u7684\u60c5\u51b5\u4e0b,\u65e0\u8bba\u6709\u65e0\u708e\u75c7\u548c/\u6216\u53d1\u73b0\u7ea4\u7ef4\u5316,\u5bf9\u809d\u810f\u809d\u810f\u809d\u810f\u7684\u8d85\u58f0\u6ce2\u68c0\u6d4b\u53d1\u73b0:", "\u4ed6\u4eec\u5efa\u8bae\u5bf9\u53ef\u80fd\u63a5\u53d7\u5316\u7597\u6216\u514d\u75ab\u6291\u5236\u5242\u6cbb\u7597\u7684\u75c5\u4eba\u8fdb\u884cHBSAg\u3001\u6297HBC\u3001\u6297HBSAg\u548c\u6c28\u57fa\u8f6c\u79fb\u9176\u6c34\u5e73\u6d4b\u8bd5,\u4ee5\u907f\u514d\u75c5\u6bd2\u590d\u53d1\u540e\u7684\u5e76\u53d1\u75c7\u3002", "\u60a3\u6709\u6162\u6027\u809d\u75c5\u7684\u75c5\u4eba,\u5982\u6211\u4eec\u75c5\u4eba\u4e00\u6837,\u6709\u4e25\u91cd\u7684\u75c5\u7406\u75c5\u7406\u635f\u4f24,\u6709\u6062\u590d\u6027\u4e59\u809d\u75c5\u7684\u5386\u53f2,\u5fc5\u987b\u7528\u5f3a\u5927\u7684\u6297\u75c5\u6bd2\u836f\u7269\u6cbb\u7597,\u5176\u9057\u4f20\u969c\u788d\u5f88\u9ad8,\u6709\u788d\u6297\u836f\u6027\u5916\u89c2,\u8fd9\u4e9b\u7279\u5f81\u5b58\u5728\u4e8e\u6838\u7ec6\u80de\u7c7b\u6bd4\u4e2d,\u5982ENTCAVir\u6216 tenofovir\u3002", "\u79fb\u690d\u809d\u810f\u6765\u81ea\u5df2\u6545\u6350\u8d60\u8005,\u5c3d\u7ba1\u5c11\u6570\u6765\u81ea\u6350\u8d60\u90e8\u5206\u809d\u810f\u7684\u6d3b\u4f53\u6350\u8d60\u8005\u3002", "\u6b64\u5e94\u7528\u7a0b\u5e8f\u5305\u542b\u4e0e\u809d\u75c5\u6709\u5173\u7684\u5177\u4f53\u4fe1\u606f\u3002", "\u73b0\u5728,\u901a\u8fc7\u4e03\u5929\u7684\u6210\u529f\u8f93\u5165\u8d28\u91cf\u5dee\u7684\u809d\u810f,\u53ef\u4ee5\u91c7\u53d6\u4e00\u7cfb\u5217\u5e7f\u6cdb\u7684\u6218\u7565,\u4f8b\u5982\u4fee\u590d\u539f\u6709\u7684\u635f\u4f24,\u6e05\u7406\u809d\u810f\u4e2d\u7684\u8102\u80aa\u77ff\u5e8a,\u751a\u81f3\u6062\u590d\u90e8\u5206\u809d\u810f\u3002", "\u809d\u529f\u80fd\u7684\u9010\u6e10\u6076\u5316\u5bfc\u81f4\u809d\u810f\u4e25\u91cd\u4e0d\u8db3,\u5728\u5165\u9662\u56db\u5929\u540e\u6b7b\u4ea1\u3002", "\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u662f\u809d\u79fb\u690d\u529f\u80fd\u5931\u8c03\u3002", "(2017) \u9152\u7cbe\u809d\u75c5:\u75c5\u56e0\u548c\u5f53\u524d\u7ba1\u7406\u3002", "\u57fa\u4e8e\u4e0a\u8ff0\u8003\u8651,\u672c\u7814\u7a76\u7684\u76ee\u6807\u662f\u67e5\u660e\u5728\u751f\u5316\u6db2\u57f9\u517b\u4e2d\u53d1\u73b0\u7684\u5fae\u751f\u7269,\u5e76\u63cf\u8ff0\u4e0e\u809d\u786c\u5316\u75c5\u4eba\u5728\u751f\u5316\u6db2\u4e2d\u611f\u67d3\u6709\u5173\u7684\u4e34\u5e8a\u7279\u5f81\u3002", "\u5728\u57c3\u53ca,Abd Elaal\u7b49\u4eba36\u5bf936\u540d\u60a3\u6709\u767d\u5589\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u548c\u767e\u65e5\u54b3\u7684\u75c5\u4eba\u8fdb\u884c\u4e86\u8bc4\u4f30,\u5176\u4e2d12\u540d\u75c5\u4eba\u7684\u98df\u76d0\u6db2\u57f9\u517b\u5bf9\u767d\u5589\u3001\u767e\u65e5\u54b3\u3001\u767e\u65e5\u54b3\u548c\u767e\u65e5\u54b3\u5177\u6709\u79ef\u6781\u5f71\u54cd\u3002", "4. \u8fc4\u4eca,\u5f88\u5c11\u6709\u75c5\u4f8b\u548c\u7cfb\u5217\u62a5\u544a\u5b58\u5728HPS\u548c\u809d\u708e\u53e3\u9ad8\u8840\u538b,\u5bf9\u8fd9\u4e9b\u75c5\u4eba\u7684\u7279\u5f81\u5c1a\u672a\u8fdb\u884c\u5145\u5206\u7814\u7a765\u3002", "1911\u5e74,\u5f17\u5170\u514b\u00b7D\u00b7\u9a6c\u6d1b\u91cc\u535a\u58eb\u9996\u5148\u5c31\u9152\u7cbe\u6027\u809d\u708e\u4f5c\u4e86\u63cf\u8ff0,\u4f46\u89c2\u5bdf\u5230\u4e86\u5176\u4ed6\u4e00\u4e9b\u809d\u75c5,\u5305\u62ec\u975e\u9152\u7cbe\u6027\u80c3\u708eNASH\u3001\u5a01\u5c14\u900a\u75c5\u3001\u6162\u6027\u80c6\u78b1\u6027\u75be\u75c5\u3001\u5bf9\u6c28\u57fa\u78f7\u916e\u548c\u809d\u7ec6\u80de\u764c\u7b49\u836f\u7269\u7684\u6bd2\u6027\u53cd\u5e94\u3002", "\u5728\u672c\u5730\u809d\u7ec4\u7ec7\u6837\u672c\u548c\u7b2c\u4e00\u6b21\u79fb\u690d\u7684\u6837\u672c\u4e2d\u68c0\u6d4b\u5230\u75c5\u6bd2\u57fa\u56e0\u7ec4\u3002", "\u4e00\u9879\u5bf9\u8d85\u8fc724\u5e74\u7684\u6bcf\u5929\u996e\u9152\u8d85\u8fc7216\u514b\u768476\u540d\u7537\u5b50\u7684\u7814\u7a76\u53d1\u73b0,\u53ea\u670922%\u7684\u7537\u5b50\u8868\u73b0\u51fa\u4e0d\u6b63\u5e38\u7684\u809d\u810f\u75c5\u7406\u5b66\u3002 \u5c3d\u7ba130%\u7684\u7537\u5b50\u60a3\u6709\u810a\u690e\u538b\u7f29\u9aa8\u6298,\u4f46\u53ea\u67094%\u7684\u7537\u5b50\u60a3\u6709\u75c7\u72b6\u3002", "\u8fd9\u4e9b\u75c5\u4eba\u8fd8\u5e94\u63a5\u53d7\u836f\u7269\u6cbb\u759715\u548c\u513f\u79d1\u624b\u672f16,\u4ee5\u63a7\u5236\u7ea4\u7ef4\u5316\u8fc7\u7a0b\u548c\u5411\u6162\u6027\u809d\u75c5\u7684\u8513\u5ef6\u3002", "\u5f53\u75c5\u4eba\u51fa\u73b0\u809d\u786c\u5316\u6216\u53cc\u8fb9\u809d\u810f\u59a5\u534f,\u4e0d\u6613\u63a5\u53d7\u5185\u76ae\u6cbb\u7597\u3001\u653e\u5c04\u5e72\u9884\u6216\u8f83\u5c0f\u7684\u809d\u810f\u5916\u79d1\u624b\u672f\u65f6,\u8fdb\u884c\u809d\u810f\u79fb\u690d\u3002", "\u6cbb\u7597\u7684\u57fa\u7840\u662f\u6539\u53d8\u751f\u6d3b\u65b9\u5f0f\u548c\u98ce\u9669\u56e0\u7d20,\u5305\u62ec\u9f13\u52b1\u953b\u70bc\u3001\u51cf\u80a5\u3001\u5065\u5eb7\u4f4e\u5361\u8def\u91cc\u996e\u98df\u548c\u6301\u7eed\u76d1\u6d4b\u4ee5\u65e9\u671f\u53d1\u73b0\u7ea4\u7ef4\u5316\u548c/\u6216\u809d\u786c\u5316,\u6b64\u5916,\u8fd8\u53d1\u5c55\u4e86\u6709\u6548\u7684\u6cbb\u7597\u65b9\u6cd5,\u5176\u526f\u4f5c\u7528\u6700\u5c0f,\u4ee5\u63a7\u5236\u75be\u75c5\u7684\u8513\u5ef6,\u5305\u62ec\u7ef4\u751f\u7d20E\u548cC\u7b49\u6297\u6c27\u5316\u5242\u7684\u65bd\u7528,\u8fd9\u4e9b\u836f\u7269\u867d\u7136\u6ca1\u6709\u626d\u8f6c\u9ad8\u6c34\u5e73\u7684\u7ec6\u80de\u76ae\u548c\u708e\u75c7,\u4f46\u5df2\u8bc1\u660e\u4f1a\u626d\u8f6c\u9ad8\u6c34\u5e73\u7684\u8f6c\u654f\u3001\u80c6\u56fa\u9187\u548c\u5408\u6c28\u9178,\u4f46\u5e76\u672a\u6539\u55844\u30016\u300118\u300141\u7684\u6297\u6c27\u5316\u5242,\u5982\u7ef4\u751f\u7d20E\u548cC\u3002", "\u6700\u8fd1,\u7531\u4e8e\u5fc3\u8840\u7ba1\u6548\u5e94,\u9521\u4e01\u80fa\u88ab\u4ece\u5e02\u573a\u4e0a\u9664\u53bb,\u800cOrlistat\u5219\u4e0e\u4e2a\u522b\u7684\u6325\u53d1\u6027\u809d\u529f\u80fd\u8870\u7aed\u75c5\u4f8b\u6709\u5173\u3002", "\u6d88\u9664\u4f11\u7720\u809d\u9636\u6bb5\u5bc4\u751f\u866b\u7684\u6cbb\u7597\u884c\u52a8DLSP:\u50ac\u7720\u52a8\u7269\u53d6\u51b3\u4e8e:", "\u76ee\u524d,\u809d\u79fb\u690d\u4fdd\u7559\u7ed9\u90a3\u4e9b\u6ca1\u6709\u4fb5\u5165\u9644\u8fd1\u8840\u7ba1\u7684\u5c0f\u80bf\u7624(\u4e00\u4e2a\u5c0f\u4e8e5\u5398\u7c73\u7684\u80bf\u7624\u62162\u81f33\u4e2a\u4e0d\u5927\u4e8e3\u5398\u7c73\u7684\u80bf\u7624)\u7684\u4eba\u3002", "\u5de6\u53f6\u809d\u96c4\u866b\u75c5\u7684\u53d1\u75c5\u7387\u6700\u9ad8,\u4e3a36%,\u5176\u6b21\u662f\u53cc\u8fb9\u809d\u96c4\u866b\u75c534%\u3002", "\u7f8e\u56fd\u548c\u897f\u6b27\u809d\u810f\u79fb\u690d\u7684\u6700\u5e38\u89c1\u8ff9\u8c61\u4e4b\u4e00\u662f\u809d\u810f\u79fb\u690d\u3002"], "train": [1, 1, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0], "chrf": [0.589, 0.628, null, null, null, null, 1.0, null, null, 1.0, null, null, 0.684, null, 0.729, 0.555, null, null, null, null, null, null, null, null, null, null, null, null, 0.475, null, null, null, null, null, null, null, null, null, null, null, 0.543, 0.687, 0.433, 0.485, null, 0.499, null, null, null, null, null, null, null, null, null, null, null, 0.574, null, null], "familiarity": [null, null, 0.444, 0.436, 0.143, 0.366, null, 0.122, 0.151, null, 0.403, 0.085, null, 0.165, null, null, 0.163, 0.136, 0.341, 0.074, 0.24, 0.169, 0.136, 0.143, 0.558, 0.243, 0.136, 0.132, null, 0.14, 0.14, 0.136, 0.357, 0.136, 0.144, 0.117, 0.136, 0.136, 0.229, 0.143, null, null, null, null, 0.136, null, 0.73, 0.446, 0.136, 0.136, 0.136, 0.136, 0.136, 0.074, 0.358, 0.136, 0.258, null, 0.783, 0.103], "x": [19.952, 21.26, 15.178, 9.696, 20.344, 8.565, 19.904, 20.043, 19.02, 19.919, 17.845, 21.233, 19.938, 20.879, 19.993, 21.282, 20.95, 19.921, 8.983, 21.245, 18.605, 20.873, 20.031, 20.27, 14.066, 18.701, 19.928, 20.339, 19.961, 19.856, 19.832, 19.964, 14.907, 20.112, 19.468, 20.265, 19.939, 19.892, 18.169, 20.277, 21.28, 19.982, 19.939, 19.941, 19.935, 18.247, 11.502, 8.445, 20.047, 19.943, 19.966, 19.901, 19.928, 21.266, 17.95, 19.887, 15.653, 21.299, 10.928, 20.307], "y": [5.759, 11.995, 9.212, 16.632, 5.458, 16.825, 5.761, 5.958, 6.088, 5.739, 8.548, 11.954, 5.798, 9.785, 5.737, 11.96, 8.834, 5.753, 17.188, 11.832, 7.202, 8.441, 5.749, 5.526, 10.144, 7.576, 5.769, 5.705, 5.76, 5.769, 5.897, 5.806, 7.032, 5.657, 5.814, 5.955, 5.742, 5.791, 7.11, 5.445, 11.943, 5.766, 5.788, 5.754, 5.817, 10.635, 13.391, 16.284, 5.687, 5.773, 5.729, 5.772, 5.763, 11.81, 7.848, 5.735, 6.154, 11.87, 14.654, 6.284], "source_id": [null, null, "0", "0", "0", "0", null, "0", "0", null, "0", "0", null, "0", null, null, "0", "0", "0", "0", "0", "0", "0", "0", "0", "0", "0", "0", null, "0", "0", "0", "0", "0", "0", "0", "0", "0", "0", "0", null, null, null, null, "0", null, "0", "0", "0", "0", "0", "0", "0", "0", "0", "0", "0", null, "0", "0"], "date": [null, null, 20210722.0, 20211125.0, 20220117.0, 20210911.0, null, 20220126.0, 20220217.0, null, 20210809.0, 20220114.0, null, 20211109.0, null, null, 20220103.0, 20211222.0, 20210913.0, 20220202.0, 20211109.0, 20211216.0, 20220326.0, 20211218.0, 20211017.0, 20211231.0, 20220214.0, 20211028.0, null, 20210717.0, 20210929.0, 20210829.0, 20220107.0, 20211129.0, 20220117.0, 20220209.0, 20210628.0, 20210815.0, 20220219.0, 20211010.0, null, null, null, null, 20220301.0, null, 20210707.0, 20220320.0, 20211217.0, 20211007.0, 20211203.0, 20211126.0, 20210821.0, 20211012.0, 20210917.0, 20210626.0, 20211009.0, null, 20211009.0, 20210622.0], "keywords": [["liver", 0.06254714077650265], ["hepatic", 0.03466886706682634], ["cirrhosis", 0.02763182443747555], ["sbp", 0.02094039504651123], ["transplantation", 0.018595107268859972], ["patients", 0.017505135889219273], ["hcv", 0.017450329205426024], ["anti", 0.01373445255908474], ["graft", 0.01327742255248383], ["chronic", 0.013182709316213697], ["viral", 0.012991530380503418], ["fibrosis", 0.01273313365296176], ["failure", 0.012326054123320265], ["hepatocytes", 0.012201695270440344], ["hepatocellular", 0.012201695270440344], ["hepatolithiasis", 0.012201695270440344], ["cases", 0.011695601985904285], ["nuclei", 0.011613164601421932], ["resections", 0.011613164601421932], ["ascitic", 0.011613164601421932], ["disease", 0.011237522564264128], ["nash", 0.011157064361315984], ["antibodies", 0.011157064361315984], ["progression", 0.011157064361315984], ["carcinoma", 0.010784728629540165], ["testing", 0.010470197523255615], ["with", 0.010181669061361769], ["associated", 0.010161989712591194], ["cultures", 0.009743647785377563]]}